Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein polypeptide E pseudogene 2 (SNRPEP2, bA390F4.4) is a processed pseudogene in the human genome, derived from the gene SNRPE, which encodes a core protein component of the spliceosomal machinery (splicing of pre-mRNA). SNRPEP2 is not transcribed into a functional protein and contains disabling mutations characteristic of processed pseudogenes, such as lack of introns, presence of polyadenylation tracts, and specific point mutations. Like most pseudogenes, SNRPEP2 does not have direct biological or pathological roles and is not considered a drug target or biomarker. If you are looking for drug targets, functional proteins, or genes with known roles in disease or therapy, this pseudogene does not qualify. If you require information about its parental gene (SNRPE), that gene does code for a functional protein with biological roles.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide E pseudogene 2 (SNRPEP2).